secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0001193125-23-303004
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics draws $25M in new term loans from Oxford Finance
------------------------------------------------------------------

- Total borrowings under the Loan Agreement now $50M, after draws of $5M (Dec 2021), $20M (Nov 2022), and this $25M.
- Loan bears floating interest at the greater of 8.25% or 1-Month CME Term SOFR + 8.25% per annum.
- Final maturity date is December 17, 2027; a final fee of 7% of aggregate principal is due at maturity or prepayment.
- Prepayment fee: 3% if within first year after funding, 2% if within second year, none thereafter.
- Proceeds use not specified; lender is Oxford Finance LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312523303004/0001193125-23-303004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312523303004/d620772d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-303004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer